Legal Opinion
Allergan, Inc. v. Barr Laboratories, Inc.
District Court, D. Delaware
Decided September 8, 2011No. Civ. No. 09-333-SLRPublishedCited by 6 opinions
1Opinion of the Court
OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”)1 by defendant Barr Laboratories, Inc. (“Barr”) on March 26, 2009 for a generic version of Lumigan® (bimatoprost ophthalmic solution), used for the treatment of high eye pressure, also called intraocular pressure (“IOP”), in people with glaucoma or ocular hypertension. Plaintiff Allergan, Inc. (“Allergan”) holds a New Drug Application (“NDA”)2 for Lumigan® 0.03% bimatoprost ophthalmic solution, and is the owner and assignee of the two Orange Book patents at…
2Cases cited29 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
24 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Erfindergemeinschaft UroPep GbR v. LillyDistrict Court, E.D. Texas · 2017
- In re Biogen 755 Patent Litig.District Court, D. New Jersey · 2018
- INVISTA North America S.à.r.l. v. M & G USA Corp.District Court, D. Delaware · 2013
- Allergan, Inc. v. Barr Laboratories, Inc.Court of Appeals for the Federal Circuit · 2013
- ASETEK Danmark A/S v. CMI USA, Inc.District Court, N.D. California · 2015
1 more not listed; retrieve them via the Exa API.